Andrew Mazar
Fundador en Actuate Therapeutics, Inc. .
Perfil
Andrew P.
Mazar is the founder of Lung Therapeutics, Inc. (2012), Tactic Pharma LLC (2010), Monopar Therapeutics, Inc. (2014), and Actuate Therapeutics, Inc. (2015).
He held the title of Director & Chief Scientific Officer at Monopar Therapeutics, Inc. and Chief Operating Officer at Actuate Therapeutics, Inc. Dr. Mazar is also the founder of ProBility Media Corp., Tempus, Inc., Wilson Therapeutics, Inc., Avidtox, Inc., Valence Therapeutics, Inc. He currently works at the National Heart, Lung & Blood Institute as a Member since 2011.
Dr. Mazar's former positions include Chairman-NCI Nanotechnology Alliance at National Cancer Institute (2011-2015) and Chief Scientific Officer at Attenuon, LLC (2000-2009).
He was also a Member at Chemistry of Life Processes Institute.
Dr. Mazar received a doctorate degree from the University of Illinois College of Medicine.
Cargos activos de Andrew Mazar
| Empresas | Cargo | Inicio |
|---|---|---|
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. operates as a private biopharmaceutical company. It offers treatment for cancer and inflammatory diseases. The company was founded by Andrew P. Mazar in 2015 and is headquartered in Fort Worth, TX. | Fundador | 01/01/2015 |
| National Heart, Lung & Blood Institute | Corporate Officer/Principal | 01/01/2011 |
Antiguos cargos conocidos de Andrew Mazar.
| Empresas | Cargo | Fin |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Fundador | 08/04/2022 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/2015 |
| Attenuon, LLC | Director Técnico/Científico/I+D | 01/01/2009 |
| Valence Therapeutics, Inc. | Fundador | - |
| Avidtox, Inc. | Fundador | - |
Formación de Andrew Mazar.
| University of Illinois College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MONOPAR THERAPEUTICS INC. | Health Technology |
| PROBILITY MEDIA CORPORATION | Commercial Services |
| Empresas privadas | 10 |
|---|---|
Lung Therapeutics, Inc.
 Lung Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lung Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in the development and commercialization of drugs for lung injury and disease. Its product pipelines include LTI-03 for the treatment of Idiopathic Pulmonary Fibrosis and LTI-01 for Loculated Pleural Effusion. The company was founded by Steven Idell and Andrew Mazar in 2012 and is headquartered in Austin, TX. | Health Technology |
| Attenuon, LLC | |
Tactic Pharma LLC
 Tactic Pharma LLC Miscellaneous Commercial ServicesCommercial Services Tactic Pharma LLC is an American company that develops pre-clinical and clinical stage compounds. The private company was founded by Andrew P. Mazar and Chandler Drew Robinson. Chandler Drew Robinson has been the CEO since incorporation. | Commercial Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. operates as a private biopharmaceutical company. It offers treatment for cancer and inflammatory diseases. The company was founded by Andrew P. Mazar in 2015 and is headquartered in Fort Worth, TX. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| National Heart, Lung & Blood Institute | Government |
| Wilson Therapeutics, Inc. | |
Tempus, Inc.
 Tempus, Inc. Beverages: Non-AlcoholicConsumer Non-Durables Part of FormCap Corp., Tempus, Inc. is a company that produces bottled beverages. The company is based in Sarasota, FL. The company was founded by Andrew P. Mazar. The CEO is Mauricio Naranjo Gonzalez. Tempus was acquired by FormCap Corp. on May 12, 2000. | Consumer Non-Durables |
| Avidtox, Inc. | |
| Valence Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Andrew Mazar